K
Katharina Lampichler
Researcher at Medical University of Vienna
Publications - 29
Citations - 509
Katharina Lampichler is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 16 publications receiving 253 citations.
Papers
More filters
Journal ArticleDOI
Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis
Macarena Simón-Talero,Davide Roccarina,Javier Martínez,Javier Martínez,Katharina Lampichler,Anna Baiges,Anna Baiges,Gavin Low,Elba Llop,Michael Praktiknjo,Martin H. Maurer,Alexander Zipprich,Michela Triolo,Guillaume Vangrinsven,R. Garcia-Martinez,R. Garcia-Martinez,Annette Dam,Avik Majumdar,Carmen Picón,Daniel Toth,Anna Darnell,Juan G. Abraldes,Marta López,Guido M. Kukuk,Aleksander Krag,Rafael Bañares,Rafael Bañares,Wim Laleman,Vincenzo La Mura,Vincenzo La Mura,Cristina Ripoll,Annalisa Berzigotti,Jonel Trebicka,Jose Luis Calleja,Puneeta Tandon,Virginia Hernández-Gea,Virginia Hernández-Gea,Thomas Reiberger,Agustín Albillos,Agustín Albillos,Emmanuel Tsochatzis,Salvador Augustin,Salvador Augustin,Joan Genescà,Joan Genescà,Sergi Quiroga,Dominic Yu,Luis Téllez,Mattias Mandorfer,Juan Carlos García-Pagán,Juan Carlos García-Pagán,Claudia Berbel,Claudia Berbel,José Ferrusquia,Michel Ble,Mari Angeles Garcia-Criado,Ernest Belmonte,Michael Ney,Cristina Margini,Stefania Casu,Giuseppe Murgia,Christiane Ludwig,Martin Rönsch,Dietrich Stoevesandt,Laura Carrion,Enrique Ramón Botella +65 more
TL;DR: The main outcomes were the incidence of complications of cirrhosis and mortality according to the presence of SPSS, and quality of life and transplantation-free survival were lower in patients with S PSS vs without.
Journal ArticleDOI
Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
Michael Praktiknjo,Macarena Simón-Talero,Julia Römer,Davide Roccarina,Javier Martínez,Katharina Lampichler,Anna Baiges,Gavin Low,Elba Llop,Martin H. Maurer,Alexander Zipprich,Michela Triolo,Geert Maleux,Annette Dam Fialla,Claus Dam,Judit Vidal-González,Avik Majumdar,Carmen Picón,Daniel Toth,Anna Darnell,Juan G. Abraldes,Marta López,Christian Jansen,Johannes Chang,Robert Schierwagen,Frank Erhard Uschner,Guido M. Kukuk,Carsten H. Meyer,Daniel Thomas,Karsten Wolter,Christian P. Strassburg,Wim Laleman,Vincenzo La Mura,Vincenzo La Mura,Cristina Ripoll,Annalisa Berzigotti,Jose Luis Calleja,Puneeta Tandon,Virginia Hernández-Gea,Thomas Reiberger,Agustín Albillos,Emmanuel Tsochatzis,Aleksander Krag,Joan Genescà,Jonel Trebicka,Sergi Quiroga,Dominic Yu,Luis Téllez,Mattias Mandorfer,Juan Carlos García-Pagán,Claudia Berbel,José Ferrusquia,Michel Ble,Mari Angeles Garcia-Criado,Ernest Belmonte,Michael Ney,Cristina Margini,Stefania Casu,Giuseppe Murgia,Christiane Ludwig,Franz Stangl +60 more
TL;DR: It is suggested that TSA >83mm2 increases the risk for oHE and mortality in liver cirrhosis and may have impact on clinical use of TSA/SPSS for risk stratification and clinical decision-making considering management of SPSS.
Journal ArticleDOI
Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study
Sazan Rasul,Marie Helene Reiter,Aysegul Ilhan,Katharina Lampichler,Ludwig Wagner,Alexandra Kautzky-Willer +5 more
TL;DR: It is suggested that the associations of Ang-2 and sTie-2 with type 2 diabetes are based on different patho-physiological mechanisms, which are independently associated with levels of HbA1c, plasma insulin and HOMA-IR in type 2 diabetic subjects.
Journal ArticleDOI
The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis.
Rafael Paternostro,Katharina Lampichler,Constanze Bardach,Ulrika Asenbaum,Clara Landler,David Bauer,Mattias Mandorfer,Remy Schwarzer,Michael Trauner,Thomas Reiberger,Arnulf Ferlitsch +10 more
TL;DR: Different Computed tomography (CT)‐based evaluation methods for muscle wasting and their prognostic value in cirrhosis are compared.
Journal ArticleDOI
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
Bernhard Scheiner,Paul René Stammet,Sebastian Pokorny,Theresa Bucsics,Philipp Schwabl,A. Brichta,Johannes Thaler,Katharina Lampichler,Ahmed Ba-Ssalamah,Cihan Ay,Arnulf Ferlitsch,Michael Trauner,Mattias Mandorfer,Thomas Reiberger +13 more
TL;DR: The findings support anticoagulation in patients with non-malignant PVT, since AC seems safe and associated with superior PVT regression rates and might also decrease hepatic injury and improve liver synthesis.